Previous 10 | Next 10 |
2024-01-23 07:32:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the worst and most deadly diseases affect our brains. In multiple sclerosis, the immune system “causes communication problems between your brain and the rest of your body,”...
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the closing of its underwritten public offering of shares of its common stock. Alector sold 10,869,566 shares of its com...
2024-01-17 17:32:22 ET Summary Alector, Inc. expects results from its phase 2 INVOKE-2 study, using AL002 for the treatment of patients with Alzheimer's disease, in Q4 of 2024. IND clearance received to begin a phase 2 study using AL101 for the treatment of patients with Alzheimer...
2024-01-17 09:37:51 ET More on Alector Alector: Good Data, Huge Cash, No Near Term Catalyst Stifel upgrades Alector to buy, stock rallies 18% Alector GAAP EPS of -$0.53 beats by $0.14, revenue of $9.11M misses by $0.86M For further details see: Alector do...
SOUTH SAN FRANCISCO, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the pricing of an underwritten public offering of 10,869,566 shares of its common stock for total gross proceeds of $75 ...
2024-01-16 16:05:26 ET More on Alector Stifel upgrades Alector to buy, stock rallies 18% Alector GAAP EPS of -$0.53 beats by $0.14, revenue of $9.11M misses by $0.86M For further details see: Alector intends to conduct a public offering of its shares
2024-01-16 11:12:10 ET Summary Alector's stock has traded mostly sideways, down 18% from last year, despite having a promising late-stage CNS pipeline, loads of cash, and two big partnerships. The company has trimmed down its pipeline from 9 programs to 3, but this is a good thing...
2023-12-14 15:01:02 ET More on Alector Alector: Milestone Uncertainty Plus Lack Of Product Revenue Alector GAAP EPS of -$0.53 beats by $0.14, revenue of $9.11M misses by $0.86M Alector achieves target enrollment for Phase 3 dementia study Seeking Alpha’...
2023-12-14 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Ocular Therape...
SOUTH SAN FRANCISCO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host two virtual events in December to discuss the Company’s TREM2 and progranulin (PGRN) programs. The e...
News, Short Squeeze, Breakout and More Instantly...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-04-16 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-18 01:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...